Jim Cramer Says He Supports Healthcare Stocks for Their Long-term Value

CNBC07:54

Boeing, NVIDIA Corp. Share Losses Lead Dow's 113-Point Drop

MarketWatch00:57

Merck Speeds Up Launch of New Keytruda Version as Patent Expiration Nears -- Barrons.com

Barron's00:34

BMO Capital Maintains Merck & Co(MRK.US) With Hold Rating, Maintains Target Price $105

Futu NewsJan 14 21:34 · Ratings

Jefferies Maintains Merck & Co(MRK.US) With Buy Rating, Maintains Target Price $150

Futu NewsJan 14 21:34 · Ratings

Merck & Co.'s Accelerated Keytruda Launch and Strategic Updates Bolster Long-term Growth Prospects

TipRanksJan 14 21:05